| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | | Total Revenue | 1,526 | 964 | | Cost of Revenue | 2,157 | 532 | | | Gross Profit | (631) | 432 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 592 | 115 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (1,223) | 317 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (120,041) | (5,420) | | Earnings Before Interest And Taxes | (1,223) | 87 | | Interest Expense | 924 | 16 | | Income Before Tax | (2,147) | 72 | | Income Tax Expense | (27) | 27 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (122,162) | (5,145) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (122,162) | (5,145) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($122,162) | ($5,145) |
|
0.49% Nasdaq 
Income Statement
